Latest News

Aramark revealed several updates that caught investors' attention this week. These include its latest annual 10-K filing, new fiscal 2026 revenue guidance, and a 14% boost to its quarterly dividend payout. See our latest analysis for Aramark. Aramark’s recent moves, including a major segment divestiture and the launch of advanced hospitality solutions, landed just as its stock has struggled to maintain upward momentum. While the past twelve months show a total shareholder return of -7.7%, its...

Wondering if KeyCorp might be a hidden value pick in today’s banking sector? Let’s dig in together and see if it deserves a spot on your radar. The stock has climbed 3.1% in the past week and is up 5.6% over the last month, signaling renewed investor interest and a possible shift in risk appetite. Recent headlines highlight industry-wide optimism as key U.S. banks benefit from improved economic outlooks and stabilizing interest rates. KeyCorp in particular has been mentioned for its...

Curious if TransMedics Group is still a bargain or if the huge price moves have put it out of reach? Let’s break down whether now is the right time to buy in or stay on the sidelines. TransMedics stock has soared 120.0% year-to-date and 68.7% over the past year, drawing fresh attention from growth investors and those tracking emerging medical technology trends. Much of this renewed interest follows industry headlines about innovations in organ transplant logistics and successful expansion...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

Shaniv Paper Industry (TASE:SHAN) just reported Q3 2025 results, posting total revenue of 234.9 million ILS and net income of 7.4 million ILS, with EPS coming in at 0.12 ILS. Over recent quarters, the company has seen revenue rise from 215.2 million ILS in Q4 2024 to 235.7 million ILS in Q1 2025, while EPS bounced back from -0.01 ILS to 0.08 ILS over the same span. With margins narrowing and profitability showing real signs of pressure, investors are left weighing how much the current risk...

Construction Partners, Inc. recently reported strong earnings results for the fourth quarter and full year ended September 30, 2025, with quarterly sales rising to US$899.85 million and net income reaching US$56.57 million. The company also reaffirmed its guidance for fiscal year 2026, projecting revenue between US$3.4 billion and US$3.5 billion and net income of US$150 million to US$155 million, reflecting management’s confidence in continued growth. We’ll explore how these robust financial...

In the past week, several leading investment banks and analysts revised their ratings and outlooks for Conagra Brands, signaling a reassessment of the company's prospects in the consumer packaged foods sector. This wave of new analyst commentary highlights increasing uncertainty around the company's future performance despite its broad market presence and operational strengths. We'll examine how this renewed analyst caution could affect Conagra Brands' investment narrative and market...

Neto M.E Holdings (TASE:NTO) just reported its Q2 2025 results, posting revenue of ₪1.2 billion and EPS of ₪6.27. Looking back, the company has seen revenue swing from ₪1.1 billion in Q1 2024 to ₪1.3 billion in Q1 2025. EPS has ranged between ₪2.68 and ₪9.33 over the past six quarters. Investor focus is now turning to how these latest results shape up in the context of recent margin movements and what they could signal going forward. See our full analysis for Neto M.E Holdings. Next up, we...

TOTO (TSE:5332) has shown steady performance lately, and investors may be curious about how recent trends could impact the company's stock. With its long-standing presence in bathroom and kitchen fixtures, the stock's progress remains a point of interest. See our latest analysis for TOTO. TOTO's shares have quietly rebounded, with a 9.4% year-to-date share price return suggesting renewed optimism among investors. Meanwhile, the 1-year total shareholder return of 3.9% reflects a more measured...

Solventum (SOLV) has set the stage for fresh investor attention by announcing a major share repurchase program. The Board approved a buyback of up to $1,000 million, which signals confidence in the company’s future direction. See our latest analysis for Solventum. Solventum’s momentum has picked up following its recently announced $1 billion buyback, a move that is catching investor attention. The company also made a noteworthy appearance at MEDICA 2025 in Germany, reinforcing its presence in...

Automatic Bank Services (TASE:SHVA) just released its latest results for Q3 2025, reporting revenue of ₪38.345 million and basic EPS of ₪0.34. Over the last twelve months, revenue climbed from ₪144.8 million to ₪153.6 million, while EPS advanced from ₪1.03 to ₪1.28, and net income expanded from ₪41.0 million to ₪51.6 million. This highlights clear, consistent gains across the board. Margin strength remains a key focus, with profitability and accelerated earnings momentum shaping this...

EyePoint Pharmaceuticals recently announced that the independent Data Safety Monitoring Committee completed its second scheduled review of the pivotal Phase 3 trial for DURAVYU, an investigational sustained-release therapy for wet age-related macular degeneration (wet AMD). This review highlights DURAVYU's potential to offer a differentiated, long-acting treatment option for both wet AMD and diabetic macular edema (DME), addressing therapeutic needs in these growing patient...

ZF Commercial Vehicle Control Systems India (NSE:ZFCVINDIA) has had a rough three months with its share price down...

Earlier this quarter, Carillon Tower Advisers highlighted Alnylam Pharmaceuticals after the company's launch of vutrisiran for transthyretin amyloidosis surpassed expectations, leading Alnylam to significantly raise its sales guidance for the therapy. This upward revision in sales projections was driven by stronger-than-forecast demand, underlining Alnylam's expanding leadership in gene-silencing therapies for rare diseases. We'll explore how Alnylam's raised guidance for its transthyretin...

Shufersal (TASE:SAE) has just posted its Q3 2025 results, reporting revenue of ₪3.7 billion and basic EPS of ₪0.72. The company has seen revenue trend from ₪4.1 billion in Q3 2024 to ₪3.7 billion in Q3 2025, with EPS moving from ₪0.89 down to ₪0.72 over the same period. Investors will be watching closely as margins take center stage this quarter. See our full analysis for Shufersal. Now let's put these latest headline numbers in perspective and see how they measure up against the prevailing...

Xenia Hotels & Resorts (XHR) just released its third quarter results. The company reported funds from operations that met expectations, while revenue fell a bit short of forecasts. Management struck a careful tone for the months ahead and lowered expectations for Q4 performance. See our latest analysis for Xenia Hotels & Resorts. Xenia Hotels & Resorts’ share price has staged a solid recovery over the past month, climbing nearly 10%. However, it is still trailing for the year with a -5% total...

Royalty Pharma recently reported a strong third quarter, with portfolio receipts rising by 11% to US$814 million and updated its full-year guidance for 2025 to reflect further growth, following the announcement by the company that its CFO sold US$2.68 million in shares through a pre-arranged plan. An interesting insight is that while short interest in Royalty Pharma’s stock increased, it remains below the industry average, pointing to relatively lower bearish sentiment from investors...

Getty Realty (GTY) announced it will issue $250 million in senior unsecured notes at a fixed 5.76% rate. The notes are set to fund in January 2026. This financing move will help repay existing credit facility balances and support future investments. See our latest analysis for Getty Realty. Getty Realty’s recent debt financing comes at a time when its share price momentum has been muted. The company posted a 2.48% one-month share price return but experienced a 3.75% decline year-to-date. Over...

Earlier this week, Sika AG announced its “Fast Forward” program, committing CHF120–150 million to accelerate digital transformation and optimize its supply chain, while also implementing structural adjustments in China and other key markets with one-off costs of CHF80–100 million in 2025. A distinctive aspect is Sika’s focus on digitalizing its global operations to create lasting efficiencies and position itself as a digital leader in construction chemicals, with the initiative expected to...

National Vision Holdings (EYE) laid out an ambitious plan for the next five years, highlighting a disciplined investment approach, a phased transformation, and significant store expansion. The company also reaffirmed its fiscal 2025 earnings outlook. Investors now have a clearer view of management's roadmap through 2030. See our latest analysis for National Vision Holdings. National Vision Holdings’ bold transformation plans come amid strong momentum for the stock, with a 167.9% share price...

If you have ever wondered whether Kohl's stock offers good value or if the recent buzz is just noise, you are not alone. Let’s dive into what is actually happening with the share price. Kohl’s has caught the market’s attention by surging a remarkable 56.5% in the past week and boasting a 75.3% return year-to-date, signaling shifting sentiment or renewed growth potential. Much of this momentum has been linked to industry chatter around M&A interest and potential strategic shifts in the retail...

La-Z-Boy Incorporated recently announced second-quarter earnings, reporting sales of US$522.48 million and net income of US$28.86 million, alongside a 10% increase in its quarterly dividend and new guidance for third-quarter sales between US$525 million and US$545 million. An interesting detail is that this marks the fifth consecutive year of double-digit dividend increases, reflecting the company’s ongoing transformation and growing confidence in its operational improvements and expansion...

Patria Investments (NasdaqGS:PAX) has delivered a 3% return over the past month, with shares closing at $15.07 most recently. Investors tracking its performance may be curious about broader trends shaping the stock’s movement. See our latest analysis for Patria Investments. Patria Investments is enjoying some solid momentum, with a 1-year total shareholder return of 31.9%, which is comfortably outpacing the broader market. A recent stretch of upbeat share price performance, including an 11%...